A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center

Indian Journal of Medical and Paediatric Oncology

Volumn 32, Issue 4, 2011, Pages 197-203

  Sengar, Manju ^a   Akhade, A ^a   Nair, R ^a   Menon, H ^a   Shet, T ^a   Gujral, S ^a   Sridhar, E ^a   Laskar, S ^a   Muckaden, M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Adolescent and young adults; adolescent and young adults malignancies; non Hodgkin lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL PROTOCOL; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HUMAN; INDIA; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84860444497     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.95140     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics 2009. CA Cancer J Clin 2009;59:225-49.
2. O'Leary M, Sheaffer J, Keller F, Shu XO, Cheson B. Lymphomas and reticuloendothelial neoplasms. In: Bleyer A, O'Leary M, Barr R, Ries LA, editors. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
3. Bleyer A. The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 2005;35:182-217. (Pubitemid 40521347)
4. Harris NL, Swerdlow SH, Jaffe ES, et al.. WHO classification of tumors of hematopoietic and lymphoid tissues. Vol. 4. Lyon: International Agency for Research on Cancer: 2008.
5. A dvani S, Pai S, Adde M, Vaidya S, Vats T, Naresh K, et al. Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India. Ann Oncol 1997;8:893-7. (Pubitemid 27452088)
6. R aje SN, Vaidya SJ, Kapoor G, Pai SK, Nair CN, Kurkure PA, et al. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia. Indian Pediatr 1996;33:556-60. (Pubitemid 26245862)
7. Jaglowski SM, Linden E, Termuhlen AM, Flynn JM. Lymphoma in adolescents and young adults. Semin Oncol 2009;36:381-418.
8. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002-6 (Pubitemid 23095683)
9. R eiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E , Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM -90. Blood 1999;94:3294-306. (Pubitemid 29536122)
10. Moleti ML, Testi Am, Giona F, Malandruccolo L, Pescarmona E , Martino P, et al. CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitts Leukemia/Lymphoma amd large B-cell lymphomas: A 15-year monocentric experience. Leuk Lymph 2007;48:551-9. (Pubitemid 46487765)
11. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 2004;104:3009-20. (Pubitemid 39507113)
12. T homas DA, Cortes J, O'Brien S, Pierce S, Faderl S, Albitar M, et al. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol 1999;17:2461-70. (Pubitemid 29368246)
13. R eiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R , Zimmermann M, et al. Intensive AL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-Cell lymphoblastic lymphoma: A BFM group report. Blood 2000;95:416-21. (Pubitemid 30041651)
14. Hoelzer D, Gokbuget N, Diget W, Faak T, Kneba M, Reutzel R , et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002;99:4379-85. (Pubitemid 34627204)
15. Williams DM, Hobson R, Imeson J, Gerrard M, McCarthy K, Pinkerton CR; et al. Anaplastic large cell lymphoma in childhood: Analysis of 72 patients treated on the United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 2002;117:812-20. (Pubitemid 34639241)
16. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-non-Hodgkins lymphomatype chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM-90. Blood 2001;97:3699-706.
17. L owe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of Children's Cancer Group study 5941. Pediatr Blood Cancer 2009;52:335-9.
18. Fanin R, Sperotto A, Silvestri F, Cerno M, Geromin A, Stocchi R , et al. The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: Results of 40 cases treated in a single center. Leuk Lymph 1999;35:159-69. (Pubitemid 29454413)